Evolent Health (EVH) News Today

Evolent Health (NYSE:EVH) Trading Up 5.5%

Scout Investments Inc. purchased a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 180,382 shares of the technology company's stock, v

Evolent Health (NYSE:EVH) Trading Up 8.5%

BNP Paribas Financial Markets boosted its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 86.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,126 shares of the technology company's stock after acquiring

Zevenbergen Capital Investments LLC increased its stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 126.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 565,625 shares of the technology company's sto

Evolent Health (NYSE:EVH) Sees Strong Trading Volume

Evolent Health (NYSE:EVH) Stock Price Down 3.6%

Shares of Evolent Health, Inc. (NYSE:EVH - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twelve brokerages that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and eleven ha

Evolent Health, Inc. (NYSE:EVH - Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 12,380,000 shares, an increase of 7.3% from the May 31st total of 11,540,000 shares. Based on an average daily volume of 1,240,000 shares, the short-interest ratio is currently 10.0 days.

Evolent Health (NYSE:EVH) Trading Down 5.5%

Hodges Capital Management Inc. lifted its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 78.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 474,746 shares of the technology company's stock after acquiring an additional 208

Evolent Health (NYSE:EVH) Hits New 1-Year Low at $20.38

Salem Investment Counselors Inc. grew its stake in Evolent Health, Inc. (NYSE:EVH - Free Report) by 1,223.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 120,121 shares of the technology company's stock

Wellington Management Group LLP raised its stake in Evolent Health, Inc. (NYSE:EVH - Free Report) by 96.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,313,157 shares of the technology company's sto

Granahan Investment Management LLC decreased its position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,903,191 shares of the technology company's

First Light Asset Management LLC acquired a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 81,722 shares o

Bellevue Group AG decreased its position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 35.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,376,992 shares of the technology company's stock after selling 1,300,123 shares duri

Shares of Evolent Health, Inc. (NYSE:EVH - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twelve brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and eleven have assigned a buy ra

Rhenman & Partners Asset Management AB grew its position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 58.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 230,000 shares of the technology company's stock after purchasing an a

Pura Vida Investments LLC purchased a new stake in Evolent Health, Inc. (NYSE:EVH - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 64,573 shares of the technology company's stock, valued at approximately $2,133,000. Evolen

Eagle Asset Management Inc. grew its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 10.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 809,540 shares of the technology company's stock after buyin

Evolent Health (NYSE:EVH) Shares Gap Down to $21.47

Norges Bank purchased a new stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,324,821 shares of the technology company's stock, valued a

Evolent Health (NYSE:EVH) Hits New 12-Month Low at $22.30

Dimensional Fund Advisors LP trimmed its holdings in Evolent Health, Inc. (NYSE:EVH - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,019,499 shares of the technology company's stock after selling 207,512 shares

Charles Schwab Investment Management Inc. grew its stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 894,272 shares

Zevenbergen Capital Investments LLC boosted its stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 1,307.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 249,750 shares of the technology company's s

Evolent Health (NYSE:EVH) Reaches New 52-Week Low at $23.29

Evolent Health (NYSE:EVH) Shares Gap Down After Analyst Downgrade

Canaccord Genuity Group decreased their price target on shares of Evolent Health from $44.00 to $41.00 and set a "buy" rating on the stock in a research report on Friday.

Victory Capital Management Inc. lessened its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 657,518 shares of the technology company's

Lisanti Capital Growth LLC acquired a new position in Evolent Health, Inc. (NYSE:EVH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,190 shares of the technology company's stock, valued

Evolent Health, Inc. (NYSE:EVH - Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 11,380,000 shares, an increase of 7.3% from the March 31st total of 10,610,000 shares. Based on an average daily volume of 934,800 shares, the days-to-cover ratio is presently 12.2 days.

Citigroup began coverage on shares of Evolent Health in a research note on Monday. They set a "buy" rating and a $40.00 price objective on the stock.

Peregrine Capital Management LLC reduced its position in Evolent Health, Inc. (NYSE:EVH - Free Report) by 14.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 306,558 shares of the technology company's